Isolated dermal fibroblasts from SSc patients have decreased mRNA expression of MMP-1, MMP-2, and MMP-3 [20], supporting the hypothesis that AHSCT restores expression and catalytic activity of some MMPs, thereby increasing the degradation of ECMs in the skin. The gene discussed is MMP2; the disease is systemic sclerosis.